← Back to Clinical Trials
Recruiting NCT07392138

NCT07392138 Understanding Newborn-Mother Synchrony at Home: Feasibility of Remote Monitoring

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07392138
Status Recruiting
Phase
Sponsor University of Turku
Condition Synchrony
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2026-04-13
Primary Completion 2026-05

Trial Parameters

Condition Synchrony
Sponsor University of Turku
Study Type OBSERVATIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 0 Years
Max Age N/A
Start Date 2026-04-13
Completion 2026-05
Interventions
Using monitoring devices

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Parents and newborns influence each other in a dynamic interaction that can be described as synchrony. Synchrony between a newborn and mother refers to the dynamic and reciprocal adaptation between the newborn and mother. In this synchrony, the mother is highly receptive and sensitive to the newborn's signals, feelings, and needs. The aim of this study is to investigate the physiological and behavioral synchrony between newborns and their mothers, and to investigate the connection between maternal heart rate variability and postpartum depression symptoms in the home environment and to evaluate the suitability of remote monitoring devices for use in the home environment. The study participants consist of 30 newborns and 30 mothers. The inclusion criteria for newborns are: 1) informed consent from the newborn's parents/guardians 2) the newborn's health status has been confirmed as normal during hospital monitoring, and 3) the newborn is less than one month old. The inclusion criteria for mothers are: 1) ability to participate in Finnish, and 2) the mother has access to an Android smartphone. Data collection will be carried out using the following remote monitoring methods: Emfit smart mattress, Zoundream Cry analyses technology, Polar Verity Sense sensor, and Empatica EmbracePlus sensor. In addition, data will be collected using background information forms, a maternal stress scale (PSS-4), a diary completed by the mother, a maternal depression questionnaire (EPDS), and questionnaires measuring the suitability of remote monitoring in the home environment, and a thematic interview. In addition, at the end of the data collection phase, the mothers participating in the study will try out the Companion App, which displays sample data on the well-being of newborns, and respond to a questionnaire on the usability of the app.

Eligibility Criteria

Inclusion Criteria, mothers: * ability to participate in Finnish * Android smart phone available Inclusion Criteria, newborns: * received informed consent from both parents/guardians * the newborn's health has been stated normal during hospital stay * the newborn is \< 1-month of age Exclusion Criteria, both (mother and newborn): Not meeting the inclusion criteria

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology